Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-15

FDA Approved: ALFUZOSIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for Alfuzosin hydrochloride from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALFUZOSIN HYDROCHLORIDE (alfuzosin hydrochloride)

Snippet

SUPPL AP for ALFUZOSIN HYDROCHLORIDE (ALFUZOSIN HYDROCHLORIDE)